Patience Kunonga
Dr Ryan Kenny
Margaret Astin
Andrew Bryant
Vasileios Kontogiannis
et al. | Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review | 2023 |
|
Jan Lecouturier
Dr Helen Bosomworth
Dr Marie Labus
Dr Robert Ellis
Professor Penny Lovat
et al. | Health professional and patient views of a novel prognostic test for melanoma: A theoretically informed qualitative study | 2022 |
|
Dr Robert Ellis
Benjamin Cosway
Dr Marie Labus
Professor Penny Lovat
| HPV sensitizes OPSCC cells to cisplatin-induced apoptosis by inhibiting autophagy through E7-mediated degradation of AMBRA1 | 2021 |
|
Professor Luke Vale
Patience Kunonga
Dr Diarmuid Coughlan
Vasileios Kontogiannis
Margaret Astin
et al. | Optimal surveillance strategies for Patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model | 2021 |
|
Dr Robert Ellis
Dr Diana Tang
Dr Batoul Nasr
Alison Greenwood
Dr Ashleigh McConnell
et al. | Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas | 2020 |
|
Patience Kunonga
Margaret Astin
Fiona Beyer
Catherine Richmond
Dr Wanwuri Akor
et al. | Prognostic risk models following AJCC Stage 1 Melanoma: a systematic review | 2019 |
|
Dr Robert Ellis
| T-type calcium channels as potential biomarkers in melanoma | 2017 |
|
Dr Diana Tang
Dr Robert Ellis
Professor Penny Lovat
| Prognostic impact of autophagy biomarkers for cutaneous melanoma | 2016 |
|
Ashleigh McConnell
Dr Robert Ellis
Professor Ruth Plummer
Professor Penny Lovat
Dr Graeme O'Boyle
et al. | The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma | 2016 |
|
Dr Robert Ellis
Dr Stamatina Verykiou
Maria Anagnostou
Derek Hill
Professor Penny Lovat
et al. | Transforming growth factor-beta mediates loss of epidermal integrity and melanoma ulceration | 2015 |
|
Dr Stamatina Verykiou
Dr Robert Ellis
Professor Penny Lovat
| Established and Emerging Biomarkers in Cutaneous Malignant Melanoma | 2014 |
|
Maria Anagnostou
Professor Penny Lovat
Dr Robert Ellis
| Proautophagic Ambra-1 as biomarker of differentiation in cutaneous squamous carcinoma | 2014 |
|
Dr Robert Ellis
Jonathan Lumsdon
Dr Nigel Kirkham
Dr Jane Renwick
Professor Penny Lovat
et al. | Prognostic Impact of p62 Expression in Cutaneous Malignant Melanoma | 2014 |
|
Ashleigh McConnell
Dr Robert Ellis
Dr Graeme O'Boyle
Professor Ruth Plummer
Dr Stamatina Verykiou
et al. | Prognostic significance of CXCR4 expression in cutaneous melanoma | 2014 |
|
Dr Robert Ellis
Maria Anagnostou
Dr Stamatina Verykiou
Martina Elias
Dr Nigel Kirkham
et al. | Transforming growth factor-beta-mediated Ambra-1 downregulation in melanoma ulceration and metastasis | 2014 |
|
Professor Mark Birch-Machin
Dr Robert Ellis
Dr Jane Renwick
Professor Penny Lovat
| Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy | 2013 |
|
Dr Robert Ellis
Dr Stamatina Verykiou
Jonathan Lumsdon
Dr Jane Renwick
Dr Nigel Kirkham
et al. | Peri-tumoural expression of pro-autophagic Ambra-1 as a prognostic biomarker for melanoma | 2013 |
|
Dr Robert Ellis
Dr Jane Renwick
Dr Nigel Kirkham
Professor Penny Lovat
| p62 as a biomarker of malignant melanoma | 2012 |
|
Dr Robert Ellis
Dr Jane Renwick
Dr Nigel Kirkham
Professor Penny Lovat
| p62: a novel diagnostic and prognostic biomarker of malignant melanoma | 2012 |
|
Dr Jane Renwick
Dr Robert Ellis
Dr Nigel Kirkham
Professor Penny Lovat
| WIPI-1: a novel autophagy inhibitory protein in melanoma | 2012 |
|
Dr Robert Ellis
Dr Jane Renwick
Christopher McKee
Dr Nigel Kirkham
Professor Penny Lovat
et al. | Biomarkers of defective autophagy in melanoma | 2011 |
|
Dr Jane Renwick
Dr Robert Ellis
Dr Nigel Kirkham
Professor Penny Lovat
| Defective autophagy in melanoma development and progression: role of oncogenic B-RAF signalling | 2011 |
|
Dr Jane Renwick
Dr Robert Ellis
Professor Penny Lovat
| Role of defective autophagy in melanoma development and progression: implication of oncogenic B-RAF signalling | 2011 |
|
Dr Robert Ellis
Dr Emma Hiscutt
Professor Penny Lovat
Dr Jane Renwick
| Role of Bcl-2 family proteins in oncogenic BRAF-induced resistance of melanoma to autophagy | 2010 |
|
